Inmaculada Alés Díaz

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial

Robin Kate Kelley, Makoto Ueno, Changhoon Yoo et al. · The Lancet · 2023 · 891 citations · Full text

Urology, Surgical Oncology, Gastrointestinal Oncology +5

A phase Ib/II study of galunisertib in combination with nivolumab in solid tumors and non-small cell lung cancer

Ernest Nadal, Mansoor N. Saleh, Santiago Ponce Aix et al. · BMC Cancer · 2023 · 54 citations · Full text

Real‐world experience of ocrelizumab in multiple sclerosis in a Spanish population

Eva Fernández-Díaz, José Antonio Pérez-Vicente, Ramón Villaverde et al. · Annals of Clinical and Translational Neurology · 2020 · 45 citations · Full text

Sequential <i>nab</i>-paclitaxel/gemcitabine followed by modified FOLFOX for first-line metastatic pancreatic cancer: The SEQUENCE trial.

Alfredo Carrato, Roberto Pazo-Cid, Teresa Macarulla et al. · Journal of Clinical Oncology · 2022 · 17 citations

Sequence Trial, Oncology, Modified Folfox +15

Secondary signet-ring cell tumour of the prostate derived from a primary gastric malignancy

Manuel Cobo, Santiago Muñoz Gallardo, José Peláez Angulo et al. · Clinical & Translational Oncology · 2005 · 14 citations

Urology, Tumoral Pathology, Medicine +7